Author

P. Dandawate

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

D. Standing· 3 shared O. Tawfik· 3 shared S. Anant· 3 shared S. Gunewardena· 3 shared S. J. Weir· 3 shared D. Subramaniam· 2 shared R. A. Jensen· 2 shared S. Choudhury· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. Standing

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

IRAK1 is a critical mediator of low molecular weight hyaluronic acid-induced stemness in high-grade serous ovarian cancer

D. Standing, P. Dandawate, S. Gunewardena, O. Covarrubias-Zambrano, K. F. Roby, D. Khabele, A. Jewell, O. Tawfik, S. H. Bossmann, A. K. Godwin, S. J. Weir, R. A. Jensen, S. Anant

This study identifies IRAK1 as a key mediator of LMW HA-induced stemness in EOC, showing its role in chemoresistance and demonstrating TCS2210 as a potential inhibitor.

bioRxiv · Sep 25, 2023 · PreprintCancer Biology

Doublecortin like kinase 1 is a target in squamous cell carcinoma

D. Standing, L. Arnold, P. Dandawate, B. Ottemann, V. Snyder, S. Ponnurangam, D. Subramaniam, P. Srinivasan, S. Choudhury, J. New, D. Kwatra, P. Ramamoorthy, B. C. Roy, M. Shadoin, R. Al-Rajabi, , S. M. Thomas

This study identifies DCLK1 as a critical target in squamous cell carcinoma, showing its role in tumor growth and demonstrating a selective inhibitor, DiFiD, that suppresses cancer progression.

bioRxiv · May 26, 2022Cancer Biology

RNA binding protein RBM3 augments kissing loop formation with lncRNAs to enhance translational control

A. A. A. Sayed, S. Choudhury, D. Subramaniam, S. Gunewardena, S. Ponnurangam, P. Dandawate, O. Tawfik, D. Standing, S. Padhye, T. Iwakuma, S. Umar, S. J. Weir, R. A. Jensen, S. M. Thomas, S. Anant

This study identifies RBM3's role in enhancing translational control via lncRNA kissing loop formation and shows its impact on tumor growth and colitis-associated cancers.

bioRxiv · Dec 14, 2021 · PreprintCancer Biology